Gene: CXCL14

9547
BMAC|BRAK|KEC|KS1|MIP-2g|MIP2G|NJAC|SCYB14
C-X-C motif chemokine ligand 14
protein-coding
5q31.1
Ensembl:ENSG00000145824 MIM:604186 Vega:OTTHUMG00000129139 UniprotKB:O95715
NC_000005.10
PubMed
ND|AD
3   
NA (AD)  NA (ND)   (Frontal_Cortex)
9.565e-2 (AD)  2.099e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OLFM20.784
SLC29A40.775
SERPINE20.76
DOK50.753
DIO20.751
SFXN50.745
NCAN0.72
CST30.712
ZNF385A0.708
AIFM30.703

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.511
OR4F29-0.463
SMYD1-0.396
OLFML2B-0.38
THEMIS-0.378
ZFP57-0.371
MCTP2-0.364
SEMA3E-0.364
SH2D1B-0.364
KEL-0.36

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of CXCL14 mRNA"28903501
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of CXCL14 mRNA"21346803
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CXCL14 mRNA"20959002
C5495433-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in decreased expression of CXCL14 mRNA25716159
C1172203-nitrobenzanthrone3-nitrobenzanthrone results in increased expression of CXCL14 mRNA19879285
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of CXCL14 mRNA"18648102
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C0275764-hydroxy-2-nonenal4-hydroxy-2-nonenal results in decreased expression of CXCL14 mRNA19191707
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
D000082AcetaminophenAcetaminophen affects the expression of CXCL14 mRNA17562736
D000108AcetylcarnitineAcetylcarnitine results in decreased expression of CXCL14 mRNA19555370
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of CXCL14 mRNA22100608
C103303alitretinoinalitretinoin results in decreased expression of CXCL14 mRNA16648578
D000643Ammonium ChlorideAmmonium Chloride affects the expression of CXCL14 mRNA16483693
C059765amphotericin B, deoxycholate drug combination"amphotericin B, deoxycholate drug combination results in increased expression of CXCL14 mRNA"22863853
C006632arsenic trioxidearsenic trioxide results in decreased expression of CXCL14 mRNA26705709
C015001arsenitearsenite results in decreased methylation of CXCL14 promoter23974009
C015001arsenitearsenite results in increased expression of CXCL14 mRNA18929588
C015001arseniteTRP53 protein affects the reaction [arsenite results in increased expression of CXCL14 mRNA]18929588
C487081belinostatbelinostat results in increased expression of CXCL14 mRNA26272509
C022921benzo(k)fluoranthenebenzo(k)fluoranthene results in increased expression of CXCL14 mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of CXCL14 mRNA25908611
D004958Estradiol[Estradiol co-treated with Progesterone] results in decreased expression of CXCL14 mRNA20660070
D004958EstradiolEstradiol results in increased expression of CXCL14 mRNA18191855
D004958Estradiol[Progesterone co-treated with Estradiol] results in decreased expression of CXCL14 mRNA17404688
D004958EstradiolEstradiol results in increased expression of CXCL14 mRNA19484750
C095105bexarotenebexarotene results in decreased expression of CXCL14 mRNA16648578
C006780bisphenol Abisphenol A results in decreased expression of CXCL14 mRNA26911702
C006780bisphenol Abisphenol A results in increased expression of CXCL14 mRNA25594700
C006780bisphenol Abisphenol A results in increased expression of CXCL14 mRNA25181051
C018475butyraldehydebutyraldehyde results in increased expression of CXCL14 mRNA26079696
D002104CadmiumCadmium results in decreased expression of CXCL14 mRNA21120746
D002185CannabidiolCannabidiol results in decreased expression of CXCL14 mRNA21542829
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of CXCL14 mRNA17484886|1991112
D002509CephaloridineCephaloridine results in increased expression of CXCL14 mRNA18500788
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL14 mRNA20938992
D003436Croton OilCroton Oil results in increased expression of CXCL14 mRNA19647056
D003474CurcuminCurcumin results in decreased expression of CXCL14 mRNA19555370
C014347decitabinedecitabine results in decreased methylation of CXCL14 promoter20562917
C014347decitabinedecitabine results in increased expression of CXCL14 mRNA20562917
D003999Dichloroacetic AcidDichloroacetic Acid results in decreased expression of CXCL14 mRNA28962523
D002945CisplatinCisplatin results in increased expression of CXCL14 mRNA27392435
D004008DiclofenacDiclofenac results in increased expression of CXCL14 mRNA26934552
D004041Dietary FatsDietary Fats results in decreased expression of CXCL14 mRNA18042831
D004041Dietary FatsDietary Fats results in decreased expression of CXCL14 mRNA21852083
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of CXCL14 mRNA24535843
D004054DiethylstilbestrolDiethylstilbestrol results in increased expression of CXCL14 mRNA25242112
D004054DiethylstilbestrolDiethylstilbestrol results in increased expression of CXCL14 mRNA17394237
D002117CalcitriolCalcitriol results in decreased expression of CXCL14 mRNA16002434
C472511dimethylarsinous aciddimethylarsinous acid results in increased expression of CXCL14 mRNA20886546
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in increased expression of CXCL14 mRNA"22485181
D004121Dimethyl SulfoxideDimethyl Sulfoxide affects the expression of CXCL14 mRNA24834073
D004137DinitrochlorobenzeneDinitrochlorobenzene results in increased expression of CXCL14 mRNA19647056
D004237DiuronDiuron results in increased expression of CXCL14 mRNA21551480
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL14 mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of CXCL14 mRNA17351261
C020748ferrous sulfateferrous sulfate results in decreased expression of CXCL14 mRNA19428942
D005485FlutamideFlutamide results in increased expression of CXCL14 mRNA21525395
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL14 mRNA20938992
D004397FonofosFonofos results in increased methylation of CXCL14 promoter22847954
D019833GenisteinGenistein results in decreased expression of CXCL14 mRNA15256057
C433788lipopolysaccharide, E. coli O26-B6"lipopolysaccharide, E. coli O26-B6 results in increased expression of CXCL14 mRNA"23090859
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of CXCL14 mRNA19428942
C015329lycopenelycopene results in decreased expression of CXCL14 mRNA19555370
D008345ManganeseManganese results in increased expression of CXCL14 mRNA17175027
C025340manganese chloridemanganese chloride results in increased expression of CXCL14 mRNA17175027
C065757meloxicammeloxicam results in decreased expression of CXCL14 mRNA23264615
C042720mercuric bromidemercuric bromide results in increased expression of CXCL14 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL14 mRNA20938992
D008727MethotrexateMethotrexate affects the expression of CXCL14 mRNA18502557
C406082monomethylarsonous acidmonomethylarsonous acid results in decreased expression of CXCL14 mRNA20886546
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of CXCL14 mRNA"25620056
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of CXCL14 mRNA"25620056
C031721naphthalenenaphthalene results in increased expression of CXCL14 mRNA18978301
C002741N-nitrosomorpholineN-nitrosomorpholine results in increased expression of CXCL14 mRNA19716841
D010081OxazoloneOxazolone results in increased expression of CXCL14 mRNA19647056
D010126OzoneOzone results in decreased expression of CXCL14 mRNA12763052
D017239PaclitaxelPaclitaxel results in increased expression of CXCL14 mRNA18754875
D000073878Palm OilPalm Oil results in decreased expression of CXCL14 mRNA18042831
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of CXCL14 mRNA26272509
D010278ParathionParathion results in increased methylation of CXCL14 promoter22847954
D052638Particulate MatterParticulate Matter results in decreased expression of CXCL14 mRNA28341207
C023036perfluorooctanoic acidperfluorooctanoic acid results in increased expression of CXCL14 mRNA19162173
D010634PhenobarbitalPhenobarbital results in decreased expression of CXCL14 mRNA19162173
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of CXCL14 mRNA26272509
C006253pirinixic acidpirinixic acid results in decreased expression of CXCL14 mRNA23811191
C006253pirinixic acidpirinixic acid results in increased expression of CXCL14 mRNA16985257
D011374Progesterone[Estradiol co-treated with Progesterone] results in decreased expression of CXCL14 mRNA20660070
D011374Progesterone[Progesterone co-treated with Estradiol] results in decreased expression of CXCL14 mRNA17404688
D011374ProgesteroneProgesterone promotes the reaction [PGR protein results in increased expression of CXCL14 mRNA]19903701
D011374ProgesteroneProgesterone results in increased expression of CXCL14 mRNA19903701
D011374ProgesteroneProgesterone affects the expression of CXCL14 mRNA17251523
D011374ProgesteroneProgesterone results in increased expression of CXCL14 mRNA19690047
C005556propionaldehydepropionaldehyde results in increased expression of CXCL14 mRNA26079696
D011441PropylthiouracilPropylthiouracil results in decreased expression of CXCL14 mRNA24780913
C059514resveratrolresveratrol results in decreased expression of CXCL14 mRNA19555370
C049705S-1,2-dichlorovinyl-N-acetylcysteine"S-1,2-dichlorovinyl-N-acetylcysteine affects the expression of CXCL14 mRNA"16844155
D012834SilverSilver affects the expression of CXCL14 mRNA27131904
D012906SmokeSmoke results in decreased expression of CXCL14 mRNA20015843
D012906SmokeSmoke affects the expression of CXCL14 mRNA23693141
C009277sodium arsenatesodium arsenate results in increased expression of CXCL14 mRNA21795629
C017947sodium arsenitesodium arsenite results in decreased expression of CXCL14 mRNA20886546
C001803tempoltempol results in decreased expression of CXCL14 mRNA19555370
C012568terbufosterbufos results in increased methylation of CXCL14 promoter22847954
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA16443690
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CXCL14 mRNA22298810
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of CXCL14 mRNA23152189
D013749TetrachlorodibenzodioxinAHRR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA]26862745
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CXCL14 mRNA26377647
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL14 mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA26862745
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA28077779
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of CXCL14 mRNA20959002
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of CXCL14 mRNA21215274
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of CXCL14 mRNA27404394|2786577
D014050TolueneToluene results in decreased expression of CXCL14 mRNA22967744
D014212TretinoinTretinoin results in decreased expression of CXCL14 mRNA21934132
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased acetylation of CXCL14 protein20562917
C012589trichostatin Atrichostatin A results in decreased expression of CXCL14 mRNA26705709
C012589trichostatin Atrichostatin A results in increased expression of CXCL14 mRNA24935251|2627250
D014302Trinitrobenzenesulfonic AcidTrinitrobenzenesulfonic Acid results in increased expression of CXCL14 mRNA15973123
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
D014635Valproic AcidValproic Acid results in decreased expression of CXCL14 mRNA23179753|2800136
D014635Valproic AcidValproic Acid results in decreased methylation of CXCL14 gene29154799
D014635Valproic AcidValproic Acid results in increased expression of CXCL14 mRNA23179753|2627250
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL14 mRNA"27188386
C111237vorinostatvorinostat results in increased expression of CXCL14 mRNA26272509
C016837zinc chloridezinc chloride results in increased expression of CXCL14 mRNA19428942
D015034Zinc OxideZinc Oxide analog results in increased expression of CXCL14 mRNA27215404
C088658zoledronic acidzoledronic acid results in decreased expression of CXCL14 mRNA24714768

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005515protein binding-IPI25416956  
GO:0008009chemokine activity-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0006935chemotaxis-TAS10049774  
GO:0006955immune response-IEA-  
GO:0007165signal transduction-TAS10049774  
GO:0007267cell-cell signaling-TAS10049774  
GO:0010469regulation of signaling receptor activity-IEA-  
GO:0045662negative regulation of myoblast differentiation-IEA-  
GO:0048839inner ear development-IEA-  
GO:2000503positive regulation of natural killer cell chemotaxis-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005615extracellular space-IEA-  
GO:0005794Golgi apparatus-IDA-  
KEGG ID KEGG Term
hsa04060Cytokine-cytokine receptor interaction
hsa04062Chemokine signaling pathway
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
29616282A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells. (2018 Jun)Yi GInflamm Res
23597004Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer. (2013 Sep)Shaykhiev RAm J Respir Cell Mol Biol
27769059Microarray analysis on the lncRNA expression profile in male hepatocelluar carcinoma patients with chronic hepatitis B virus infection. (2016 Nov 15)Niu JOncotarget